Atlas Trials

BAY1238097, First in Man

Clinical trial NCT02369029 · TERMINATED

Trial details

NCT number
NCT02369029
Sponsor
Bayer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2015-03-01
Primary completion
2016-01-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.